Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Morningside Healthcare Ltd., Unit C, Harcourt Way, Leicester, LE19 1WP, United Kingdom
Emerres 1.5 mg tablet.
| Pharmaceutical Form |
|---|
|
Tablet. Each tablet is round, white to off-white, uncoated flat tablets debossed ‘145’ on one side and plain on the other side. |
Each tablet contains 1.5 mg of levonorgestrel.
Excipients with known effects: each tablet contains 154 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levonorgestrel |
The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Blister composed of PVC film coated with PVDC and aluminium foil.
Pack size: 1 tablet.
Morningside Healthcare Ltd., Unit C, Harcourt Way, Leicester, LE19 1WP, United Kingdom
PL 20117/0138
10/11/2014
| Drug | Countries | |
|---|---|---|
| EMERRES | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
